Skip to main content
. Author manuscript; available in PMC: 2016 Mar 3.
Published in final edited form as: Expert Opin Orphan Drugs. 2015 Apr 13;3(5):491–504. doi: 10.1517/21678707.2015.1025746

Figure 2.

Figure 2

a) Comparison of immunofluorescence staining of permeabilized and non-permeabilized WT and Neu1−/− macrophages with LAMP1 antibodies against either the C-terminal cytosolic domain (L1418) or the glycosylated luminal domain (1D4B) of LAMP1; b) Bone sections from 2 months old Neu1−/− and control mice were stained with the anti-VCAM-1; Strong immunoreactivity was observed only in the sections from the control in the region lining the bone (arrows). Adapted from Yogalingam et al Dev. Cell 2008, with permission of Elsevier.